These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7053260)

  • 41. [Efficacy of tegafur/uracil plus oral leucovorin therapy for advanced or recurrent colorectal cancer].
    Kabashima A; Sakaguchi Y; Okita K; Yamamura S; Ojima Y; Nishizaki T; Tashiro H; Matsuzaka T
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1935-8. PubMed ID: 16282730
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Double modulation with methotrexate and L-leucovorin of weekly 24- hour fluorouracil infusion in fluorouracil-refractory colorectal cancer.
    Colleoni M; Nelli P; Vicario G; Pancheri F; Sgarbossa G; Manente P
    Anticancer Res; 1996; 16(5B):3101-4. PubMed ID: 8920775
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Relationship between expression of thymidylate synthase and colorectal carcinoma].
    Yu ZG; Sun JZ; Zhang Q; Jia HY; Wang JX
    Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1432-5. PubMed ID: 15500737
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phase II study of a 21-day continuous infusion schedule with epirubicin in metastatic colorectal cancer.
    Greidanus J; Willemse PH; Sleijfer DT; Mulder NH; Verschueren RC; Nieweg R; de Vries EG
    Eur J Cancer Clin Oncol; 1988 Apr; 24(4):801-2. PubMed ID: 3164271
    [No Abstract]   [Full Text] [Related]  

  • 45. Phase II study of cyclophosphamide and cytarabine in the treatment of metastatic adenocarcinoma of the colon and rectum.
    Denefrio JM; Kaplan RS; Eisenberger MA; Lessner HE
    Cancer Treat Rep; 1981; 65(1-2):163-4. PubMed ID: 7226166
    [No Abstract]   [Full Text] [Related]  

  • 46. [Low-dose cisplatin added to continuous infusion of 5-fluorouracil or oral administration of UFT for inoperable advanced or recurrent colorectal cancer].
    Asano M; Mori T; Takahashi K; Yasuno M
    Gan To Kagaku Ryoho; 1997 Jan; 24(1):55-60. PubMed ID: 9020946
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Chronotherapy combining 5-fluorouracil, folinic acid and carboplatin as first line treatment in metastatic colorectal cancer. A phase 2 study].
    Focan C; Kreutz F; Longrée L; Graas MP; Focan-Henrard D; Moeneclaey N; David A; Biquet JF; Materne R; Weerts J; Delforge M
    Pathol Biol (Paris); 2005 Jun; 53(5):273-6. PubMed ID: 15939137
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901.
    ; Ryan DP; Niedzwiecki D; Hollis D; Mediema BE; Wadler S; Tepper JE; Goldberg RM; Mayer RJ
    J Clin Oncol; 2006 Jun; 24(16):2557-62. PubMed ID: 16636336
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX-4) as salvage chemotherapy in patients with pretreated colorectal cancer.
    Shitara K; Munakata M; Muto O; Kasai M; Okada R; Mitobe S; Sakata Y
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1079-84. PubMed ID: 17637544
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [An institution-randomized trial of 5-fluorouracil and l-leucovorin therapy given monthly versus every two months to patients with advanced colorectal carcinoma].
    Hasegawa S; Akaike M; Yamamoto Y; Shiraishi R; Ozawa Y; Suzuki H; Miyazaki T; Kasahara A; Makino T; Tamura I; Tanabe H; Rino Y
    Gan To Kagaku Ryoho; 2004 May; 31(5):729-33. PubMed ID: 15170981
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phase I-II trial of methyl-GAG in advanced colon cancer. a Southwest Oncology Group pilot study.
    Myers JW; Knight WA; Livingston RB; Fabian C; Costanzi J
    Cancer Clin Trials; 1981; 4(3):277-9. PubMed ID: 7285275
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A new sequential chemotherapy of methotrexate with 5-fluorouracil against advanced colo-rectal cancer].
    Fujiki T; Futatsuki K; Akazawa S; Yamamoto K; Miyazaki M; Kanda Y; Amemiya K; Uchida N; Oishi T
    Gan To Kagaku Ryoho; 1993 Apr; 20(5):603-9. PubMed ID: 8470917
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Retrospective analysis of tegafur/uracil (UFT) plus oral leucovorin (LV) regimen in patients with advanced colorectal cancer].
    Sato Y; Inaba Y; Yamaura H; Shimamoto H; Nishiofuku H; Oyama T; Kanemitsu Y; Sawaki A; Arai Y; Muro K
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):887-90. PubMed ID: 16835473
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Efficacy of m-FOLFOX6 therapy for colorectal cancer in elderly patients].
    Young Kim W; Maeda K; Noda E; Fukunaga S; Inoue T; Kaizaki R; Shinto O; Wada K; Nakano T; Hirakawa K
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1833-6. PubMed ID: 18030018
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical note. Phase II study of 1-aminocyclopentanecarboxylic acid (NSC-1026) in patients with cancer.
    Aust JB; Andrews NC; Schroeder JM; Lawton RL
    Cancer Chemother Rep; 1970 Aug; 54(4):237-41. PubMed ID: 4946007
    [No Abstract]   [Full Text] [Related]  

  • 56. Observations on the human pharmacology of cycloleucine.
    Muggia FM; Loew J; Horwitz S
    Cancer Treat Rep; 1977 Nov; 61(8):1561-3. PubMed ID: 922758
    [No Abstract]   [Full Text] [Related]  

  • 57. Phase II evaluation and plasma pharmacokinetics of high-dose intravenous 6-thioguanine in patients with colorectal carcinoma.
    Konits PH; Egorin MJ; Van Echo DA; Aisner J; Andrews PA; May ME; Bachur NR; Wiernik PH
    Cancer Chemother Pharmacol; 1982; 8(2):199-203. PubMed ID: 7105383
    [No Abstract]   [Full Text] [Related]  

  • 58. Synergistic suppression of the hyperacute form of experimental allergic encephalomyelitis by tilorone and cycloleucine.
    Levine S; Sowinski R
    Proc Soc Exp Biol Med; 1977 Dec; 156(3):457-60. PubMed ID: 594075
    [No Abstract]   [Full Text] [Related]  

  • 59. Synergistic growth inhibiting effect of nitrous oxide and cycloleucine in experimental rat leukaemia.
    Kroes AC; Lindemans J; Abels J
    Br J Cancer; 1984 Dec; 50(6):793-800. PubMed ID: 6498076
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phase II study of high-dose intermittent cycloleucine in colorectal malignancies.
    Dindogru A; Leichman LP; Cummings G; Baker LH
    Cancer Treat Rep; 1982 Jan; 66(1):203-4. PubMed ID: 7053260
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.